BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36858026)

  • 1. Customized Citrate Anticoagulation versus No Anticoagulant in Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: A Prospective Randomized Controlled Trial.
    Ratanarat R; Phairatwet P; Khansompop S; Naorungroj T
    Blood Purif; 2023; 52(5):455-463. PubMed ID: 36858026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.
    Schilder L; Nurmohamed SA; Bosch FH; Purmer IM; den Boer SS; Kleppe CG; Vervloet MG; Beishuizen A; Girbes AR; Ter Wee PM; Groeneveld AB;
    Crit Care; 2014 Aug; 18(4):472. PubMed ID: 25128022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution.
    Morabito S; Pistolesi V; Tritapepe L; Zeppilli L; Polistena F; Strampelli E; Pierucci A
    Crit Care; 2012 Jun; 16(3):R111. PubMed ID: 22738289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: A retrospective case-control study.
    Yu Y; Bai M; Ma F; Zhang W; Li Y; Zhao L; Li L; Zhou M; Li L; Sun S
    PLoS One; 2020; 15(5):e0232516. PubMed ID: 32369523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding.
    Betjes MG; van Oosterom D; van Agteren M; van de Wetering J
    J Nephrol; 2007; 20(5):602-8. PubMed ID: 17918147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two regional citrate anticoagulation modalities for continuous renal replacement therapy by a prospective analysis of safety, workload, effectiveness, and cost.
    Cassina T; Villa M; Soldani-Agnello A; Zini P
    Minerva Anestesiol; 2021 Dec; 87(12):1309-1319. PubMed ID: 34527405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study.
    Yu Y; Bai M; Wei Z; Zhao L; Li Y; Ma F; Sun S
    Ren Fail; 2020 Nov; 42(1):748-758. PubMed ID: 32718221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K; Jearnsujitwimol O; Susantitaphong P; Kijkriengkraikul N; Leelahavanichkul A; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study.
    Nurmohamed SA; Vervloet MG; Girbes AR; Ter Wee PM; Groeneveld AB
    Blood Purif; 2007; 25(4):316-23. PubMed ID: 17700015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified regional citrate anticoagulation protocol for CVVH, CVVHDF and SLED focused on the prevention of KRT-related hypophosphatemia while optimizing acid-base balance.
    Di Mario F; Sabatino A; Regolisti G; Pacchiarini MC; Greco P; Maccari C; Vizzini G; Italiano C; Pistolesi V; Morabito S; Fiaccadori E
    Nephrol Dial Transplant; 2023 Sep; 38(10):2298-2309. PubMed ID: 37037771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-Citrate Anticoagulation during Continuous Renal Replacement Therapy in Patients with Metformin Intoxication: A Case Series, Mathematical Estimation of Citrate Accumulation, and Literature Review.
    Brunoni B; Zadek F; Mulazzani F; Verza G; Marrazzo F; Spina S; Protti A; Fumagalli R; Langer T
    Blood Purif; 2023; 52(9-10):802-811. PubMed ID: 37673054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citrate anticoagulation for continuous venovenous hemofiltration.
    Oudemans-van Straaten HM; Bosman RJ; Koopmans M; van der Voort PH; Wester JP; van der Spoel JI; Dijksman LM; Zandstra DF
    Crit Care Med; 2009 Feb; 37(2):545-52. PubMed ID: 19114912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation options for continuous renal replacement therapy in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.
    Zhou Z; Liu C; Yang Y; Wang F; Zhang L; Fu P
    Crit Care; 2023 Jun; 27(1):222. PubMed ID: 37287084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial.
    Hetzel GR; Schmitz M; Wissing H; Ries W; Schott G; Heering PJ; Isgro F; Kribben A; Himmele R; Grabensee B; Rump LC
    Nephrol Dial Transplant; 2011 Jan; 26(1):232-9. PubMed ID: 20876598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choice of replacement solution and anticoagulant in continuous venovenous hemofiltration.
    Palsson R; Laliberte KA; Niles JL
    Clin Nephrol; 2006 Jan; 65(1):34-42. PubMed ID: 16429840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    BMC Nephrol; 2013 Oct; 14():232. PubMed ID: 24156306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different modalities of continuous renal replacement therapy with regional sodium citrate anticoagulation in paediatric patients.
    He J; Xiao Z; Zhou X; Cao J; Kang X; Zhang X
    Int J Artif Organs; 2022 Dec; 45(12):997-1005. PubMed ID: 35903018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mode of CVVH with regional citrate anticoagulation compared to no anticoagulation for acute kidney injury patients at high risk of bleeding.
    Gao J; Wang F; Wang Y; Jin D; Tang L; Pan K
    Sci Rep; 2019 Apr; 9(1):6607. PubMed ID: 31036927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.